Li, S., Wu, J., Huang, O., He, J., Zhu, L., Chen, W., . . . Shen, K. (2020). HER2 positivity is not associated with adverse prognosis in high-risk estrogen receptor-positive early breast cancer patients treated with chemotherapy and trastuzumab. Breast.

Li, Shuai, Jiayi Wu, Ou Huang, Jianrong He, Li Zhu, Weiguo Chen, Yafen Li, Xiaosong Chen, và Kunwei Shen. "HER2 Positivity Is Not Associated With Adverse Prognosis in High-risk Estrogen Receptor-positive Early Breast Cancer Patients Treated With Chemotherapy and Trastuzumab." Breast 2020.

Li, Shuai, et al. "HER2 Positivity Is Not Associated With Adverse Prognosis in High-risk Estrogen Receptor-positive Early Breast Cancer Patients Treated With Chemotherapy and Trastuzumab." Breast 2020.